RVL Pharmaceuticals plc (RVLPQ)

RVL Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Cash & Equivalents	44.54	40.44	114.05	95.87	70.83
Cash & Cash Equivalents	44.54	40.44	114.05	95.87	70.83
Cash Growth	10.14%	-64.54%	18.97%	35.34%	103.88%
Receivables	3.03	2.13	3.15	43.91	56.42
Inventory	0.78	0.84	1.83	21.31	24.38
Other Current Assets	8.62	15.96	54.12	11.55	20.72
Total Current Assets	56.98	59.38	173.15	172.63	172.36
Property, Plant & Equipment	1.79	2.23	4.34	35.22	31.26
Goodwill and Intangibles	69.75	83.06	90.94	254.84	591.25
Other Long-Term Assets	0	0	102.51	0.56	0.75
Total Long-Term Assets	71.54	85.29	197.8	290.63	623.26
Total Assets	128.51	144.67	370.95	463.26	795.62
Accounts Payable	2.41	3.78	3.13	8.5	24.87
Current Debt	1.88	3.25	1.22	2.19	1.89
Other Current Liabilities	15.44	13.08	51.44	65.25	87.24
Total Current Liabilities	19.72	20.11	55.78	75.94	114
Long-Term Debt	55.61	44.39	220.4	271.11	266.94
Other Long-Term Liabilities	2.08	3.44	0.91	1.5	30.84
Total Long-Term Liabilities	57.69	47.83	221.31	272.61	297.78
Total Liabilities	77.42	67.94	277.09	348.55	411.78
Total Debt	57.49	47.65	221.62	273.3	268.83
Debt Growth	20.66%	-78.50%	-18.91%	1.66%	-16.17%
Retained Earnings	-569.22	-517.53	-452.61	-373.02	-102.12
Comprehensive Income	0	1.7	-2.23	-2.23	-1.85
Shareholders' Equity	51.09	76.73	93.86	114.71	383.85
Net Cash / Debt	-12.95	-7.2	-107.56	-177.43	-198
Net Cash Per Share	-0.14	-0.11	-1.77	-3.39	-4.37
Working Capital	37.25	39.27	117.37	96.69	58.36
Book Value Per Share	0.57	1.14	1.55	2.19	8.48

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).